China, Aug. 27 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Chimeric Antigen Receptor T-Cell Immunotherapy for Childhood Refractory/Relapsed Neuroblastoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130891
Registration Time: 2026/08/26
Type: Interventional study
Primary Sponsor: Shanghai Children's Medical Center, Affiliated to Shanghai Jiaotong University, School of Medicine
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=266332
Published by HT Digital Content Services with permission from Health Daily Digest....